Workflow
Partnership Strategy
icon
Search documents
Novavax (NVAX) FY Earnings Call Presentation
2025-06-11 13:44
Goldman Sachs 46th Annual Global Healthcare Conference June 11, 2025 Cautionary Note Regarding Forward-Looking Statements This presentation includes forward-looking statements. These forward-looking statements generally can be identified by the use of words such as "anticipate," "expect," "plan," "could," "may," "will," "believe," "estimate," "forecast," "goal," "project," and other words of similar meaning. These forward-looking statements address various matters including Novavax's corporate strategy and ...
TAT Technologies Expands MRO Partnership with Leading International Cargo Carrier; APU maintenance for Boeing 737, 757, 767, and Airbus A300 fleets
Prnewswire· 2025-05-21 22:36
TAT Technologies Expands MRO Partnership with Leading International Cargo Carrier; 5-Year Contract Valued at $40-55 MillionAgreement expands APU maintenance support for Boeing 737, 757, 767, and Airbus A300 fleets and adds support for Boeing 777 fleetsNETANYA, Israel, May 21, 2025 /PRNewswire/ -- TAT Technologies Ltd. (NASDAQ: TATT), (TASE: TAT Tech), a leading provider of innovative products and services for the commercial and defense aviation markets, announced today the signing of a five-year maintenance ...
Lexicon Pharmaceuticals(LXRX) - 2025 Q1 - Earnings Call Transcript
2025-05-13 22:02
Lexicon Pharmaceuticals (LXRX) Q1 2025 Earnings Call May 13, 2025 05:00 PM ET Company Participants Lisa DeFrancesco - SVP of Investor Relations & Corporate CommunicationsMike Exton - CEO & DirectorScott Coiante - SVP and CFOAndrew Tsai - SVPCraig Granowitz - SVP & Chief Medical OfficerYigal Nochomovitz - DirectorLander Egaña-Gorroño - Senior Associate, Biotech Equity Research Conference Call Participants Roanna Ruiz - Senior Managing Director, Biotechnology AnalystYasmeen Rahimi - Sr. Research Analyst Opera ...
Lexicon Pharmaceuticals(LXRX) - 2025 Q1 - Earnings Call Transcript
2025-05-13 22:00
Lexicon Pharmaceuticals (LXRX) Q1 2025 Earnings Call May 13, 2025 05:00 PM ET Speaker0 Welcome to the Lexicon Pharmaceuticals First Quarter twenty twenty five Financial Results Conference Call. At this time, all participants are in a listen only mode. Following management's prepared remarks, we will hold a brief question and answer session. As a reminder, this call is being recorded today, 05/13/2025. I will now turn the call over to Lisa DiFrancesco, SVP, Investor Relations and Corporate Communications for ...